APA (7th ed.) Citation

Yasunori Ishihara, Haruo Kuroki, Hidenobu Hidaka, Kazuyuki Iwai, Keiko Wan, Masayoshi Shirakawa, & Miyuki Sawata. (2023). Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028). Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yasunori Ishihara, Haruo Kuroki, Hidenobu Hidaka, Kazuyuki Iwai, Keiko Wan, Masayoshi Shirakawa, and Miyuki Sawata. Safety and Immunogenicity of a 15-valent Pneumococcal Conjugate Vaccine in Japanese Healthy Infants: A Phase I Study (V114-028). Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Yasunori Ishihara, et al. Safety and Immunogenicity of a 15-valent Pneumococcal Conjugate Vaccine in Japanese Healthy Infants: A Phase I Study (V114-028). Taylor & Francis Group, 2023.